Author: CannabisNewsWire (CNW)

About CannabisNewsWire CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge. To receive SMS text alerts from CannabisNewsWire, text “CANNABIS” to 21000 (U.S. Mobile Phones Only) For more information please visit https://www.CannabisNewsWire.com Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

420 with CNW — German Marijuana Imports Reached Record Levels in 2023

Germany saw a significant surge in its marijuana imports for scientific and medical purposes last year, reaching a record high, indicating a growing interest from international businesses eyeing opportunities in Europe’s largest federally regulated medical cannabis market. According to the latest data from the Federal Institute for Drugs & Medical Devices (BfArM), the country imported 36.4 tons (31,398 kilograms) of marijuana products last year. This marks a notable increase of 26.2% compared to the previous year’s import volume of 24,876 kilograms.

The trend of increasing imports has been consistent through the years. In 2022, the country saw imports of 27.4 tons (24,876 kilograms) of marijuana, reflecting a 19.8% increase from the previous year. The year 2021 saw imports of 22.9 tons (20,771 kilograms), representing a significant surge of 77% over the previous year.

In 2020, imports totaled 12.8 tons (11,746 kilograms), indicating a 46% increase from 2019, while in 2019, Germany imported 8.9 tons (8,057 kilograms) of marijuana, which was an 80% increase from the previous year’s imports. While some of these imports are re-exported to other European Union countries annually, experts suggest that the data underscores the rapid growth of the industry.

Only three businesses were authorized to grow medical cannabis in 2019; these companies were given strict output targets that would last for four years. Due to this restriction, cannabis had to be imported from overseas to meet demand. However, changes in marijuana law have the potential to reduce its dependence on imports in the future. The new law eliminates the quota system, allowing companies to apply for permits to grow medical cannabis through the agency.

Furthermore, the recent revision of the marijuana law, effective April 1, 2024, has reclassified the substance, removing it from the list of narcotics. This regulatory change simplifies the process for patients seeking medical marijuana because they will no longer be required to have a narcotic prescription form. Standard prescriptions will now suffice, likely stimulating demand in the market.

Despite the optimism for increased domestic cultivation, Germany is expected to continue relying on significant imports in the foreseeable future. German-based Demecan’s managing director, Von der Groeben, pointed out Article 21 of the UN Single Convention on Narcotic Drugs, which suggests that domestic demand must be met before imports can be halted. However, he acknowledges that achieving self-sufficiency in marijuana production may take several years.

Canada remained the primary supplier of marijuana to the German market last year, accounting for approximately 50% of imports. Portugal came in second, while the Netherlands was the third-largest supplier.

The further easing of marijuana laws in Germany could create additional opportunities that major players in the North American cannabis landscape, such as Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF), may look to exploit as they expand their footprint in different legal markets.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of an article each business day at 4:20 p.m. Eastern – a tribute to the time synonymous with cannabis culture. The concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive SMS alerts from CNW, text CANNABIS to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: https://www.CannabisNewsWire.com/Disclaimer

CannabisNewsWire
Denver, CO
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is powered by IBN

CannabisNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Launches New Research Program to Evaluate DehydraTECH-GLP-1 Drugs

Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug delivery platforms, has announced an applied research program to evaluate certain molecular characteristics of DehydraTECH processed with the glucagon-peptide 1 (“GLP-1”) drug, semaglutide, related to its mode of action and performance. According to the announcement, the research will be conducted in partnership with the National Research Council of Canada (“NRC”). “We are excited about our partnership with the NRC for the mode of action molecular characterization of DehydraTECH-GLP-1 drugs. This work program could potentially provide data to assist Lexaria’s efforts in partnering with the pharmaceutical industry for the most rapid introduction possible of DehydraTECH with GLP-1 drugs,” said John Docherty, president of Lexaria. “The NRC was selected for this important work program because of its high-caliber research facilities and capabilities, further building upon the previous history of successful research projects between Lexaria and the NRC.”

To view the full press release, visit https://cnw.fm/DYsJy

About Lexaria Bioscience Corp.

DehydraTECH(TM) is Lexaria’s patented drug delivery formulation and processing platform technology that improves the way active pharmaceutical ingredients (“APIs”) enter the bloodstream through oral delivery. Since 2016, Lexaria has developed and investigated DehydraTECH with a variety of beneficial molecules in oral and topical formats. DehydraTECH has repeatedly demonstrated the ability to increase bio-absorption and has also evidenced an ability to deliver some drugs more effectively across the blood brain barrier, which Lexaria believes to be of particular importance for centrally active compounds. Lexaria operates a licensed in-house research laboratory and holds a robust intellectual property portfolio with 41 patents granted and many patents pending worldwide. For more information, visit the company’s website at www.LexariaBioscience.com.

NOTE TO INVESTORS: The latest news and updates relating to LEXX are available in the company’s newsroom at https://cnw.fm/LEXX

About CannabisNewsWire

CannabisNewsWire (“CNW”) is a specialized communications platform with a focus on cannabis news and the cannabis sector. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled recognition and brand awareness. CNW is where breaking news, insightful content and actionable information converge.

To receive SMS alerts from CNW, text CANNABIS to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: https://www.CannabisNewsWire.com/Disclaimer

CannabisNewsWire
Denver, CO
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is powered by IBN

BizCann Expo 2024 by ZJ Events, is Coming to Latin America

Date: May 18-19, 2024
Venue: Plaza Mayor, Medellin Colombia

ZJ Events brings BizCann Expo to Latin America, hosting the BizCann Expo 2024 in Medellin, Colombia, May 18-19, 2024. This event promises to boost cannabis investments and offer phenomenal cannabis business avenues in the region. The BizCann Expo 2024 conference offers cannabis traders, entrepreneurs, legislators, enthusiasts, and influencers, two days of networking, innovation, business, and education on the cannabis industry.

The BizCann Expo 2024 is a premier event that will connect the leading American cannabis markets for better opportunities. It will boost cannabis trade by offering a networking platform to all the cannabis businesses from all segments. 30+ eminent speakers of the industry will present insightful sessions covering the latest trends, hurdles, legislations, regulations, as well the innovations in this field.

BizCann Expo 2024 has partnered with well-known brands, from plant touching, non-plant touching, as well as ancillary services in the canna industry. The wide gamut of speakers comprises of manufacturers, professionals, service providers, legislators, software and accounting wizards, all catering to the cannabis industry.

The attendee list consists of growers, entrepreneurs, C-level executives, accountants, legal advisors, investors as well as newbies developing a foothold in the Latin American cannabis industry. Attendees can connect with the industry people and build their own cannabis community, and will also gain insights into the legal and licensing aspects of business. During the networking sessions, they can connect with industry veterans and peers to establish long-term business ties across the American landscape.

With its proximity to the US, Colombia offers the perfect venue for the expo. In addition, Medellin has great connecting facilities, a favourable legislation framework, and a vibrantly rich culture and history.

To know more, please visit https://cnw.fm/rUlkW.

About CannabisNewsWire

CannabisNewsWire (“CNW”) is a specialized communications platform with a focus on cannabis news and the cannabis sector. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled recognition and brand awareness. CNW is where breaking news, insightful content and actionable information converge.

To receive SMS alerts from CNW, text CANNABIS to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: https://www.CannabisNewsWire.com/Disclaimer

CannabisNewsWire
Denver, CO
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is powered by IBN

420 with CNW — Citrus-Smelling Cannabis Compound Has Potential to Manage THC-Induced Paranoia

Cannabis, when used in the right amount, can have calming effects, easing anxiety and alleviating pain. However, determining the appropriate dosage can be challenging. Consuming even slightly too much can lead to a starkly different experience, often referred to as “paranoia” by recreational users, characterized by panic and acute anxiety.

Recent research published in Drug and Alcohol Dependence suggests that one of the aromatic compounds in marijuana, d-limonene, may counteract these anxiety-causing effects. The citrusy compound, found naturally in marijuana, could potentially help users avoid experiencing anxiety attacks, which would increase cannabis’ therapeutic effects.

Marijuana contains more than 500 chemical components, with THC being the primary psychoactive component responsible for the “high.” Additionally, cannabinoids such as CBD are thought to influence the overall experience. Terpenes, aromatic compounds in marijuana, contribute to its unique scent. There’s a longstanding belief in the cannabis community that ingesting products created from the entire plant rather than isolated compounds, including CBD or THC, produces a different, more beneficial effect, a concept known as the entourage effect.

However, the scientific evidence for the effect remains unclear due to the many chemicals involved. Ryan Vandrey, a behavioral pharmacologist at Johns Hopkins University, explains that, despite the lack of conclusive evidence for the entourage effect, it has significantly influenced how marijuana strains are bred and marketed. This concept originated partly from studies suggesting that terpenes such as d-limonene may have anxiety-reducing properties, as indicated in a review paper in 2011 by Ethan Russo.

To investigate whether d-limonene could indeed alleviate THC-induced anxiety, Vandrey and his team conducted a double-blind study involving participants who had previously experienced anxiety while using marijuana. The results showed that increasing concentrations of d-limonene relative to THC led to fewer reported symptoms of anxiety, suggesting a potential therapeutic effect. This effect was most significant when participants inhaled a high ratio of d-limonene to THC, a ratio not typically found in natural marijuana strains.

However, Vandrey cautioned about the preliminary nature of these findings and the need for further research. While d-limonene appears to target anxiety specifically without affecting other aspects of the marijuana high, its mechanism of action remains unclear. Additionally, the study’s limitations, such as using vaporized marijuana and high concentrations of d-limonene, need to be addressed in future studies.

Despite these limitations, the study opens the door to further exploration of terpenes’ role in marijuana effects. Researchers are already investigating other terpenes found in marijuana to better understand their impact.

The potential of terpenes such as d-limonene isn’t entirely new. Folk remedies dating back centuries suggest that compounds found in citrus fruits could counteract the negative effects of cannabis. While these remedies have historical backing, scientific research is just beginning to uncover their true potential.

The entire cannabis industry, including leading companies such as Tilray Brands Inc. (NASDAQ: TLRY) (TSX: TLRY), could pay attention to the outcomes of any additional studies exploring the effects of d-limonene because it could open new opportunities for custom cannabis products.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of an article each business day at 4:20 p.m. Eastern – a tribute to the time synonymous with cannabis culture. The concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive SMS alerts from CNW, text CANNABIS to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: https://www.CannabisNewsWire.com/Disclaimer

CannabisNewsWire
Denver, CO
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is powered by IBN

420 with CNW — New Survey: 6 in 10 Americans Consider Cannabis Safer Than Tobacco, Alcohol

According to a new survey, the majority of Americans believe that marijuana is less detrimental to health than tobacco and alcohol. According to the YouGov poll, 64% of participants believe that regular alcohol consumption is riskier than marijuana use, and 63% believe that regular tobacco use is also riskier. The survey conducted from April 5–8, 2024, involved 1,148 adults.

Contrastingly, only a small fraction — 14% — believes that cannabis usage poses a greater threat than regular alcohol consumption. Additionally, 16% of participants stated that marijuana is more detrimental than tobacco. In total, 53% of those surveyed indicated that both tobacco and alcohol are more detrimental to health than cannabis.

These findings align with other recent surveys, such as one conducted by Gallup, which revealed that Americans generally perceive cannabis as less detrimental than cigarettes, alcohol and vaping. Moreover, the survey noted that marijuana use has overtaken cigarette consumption in the United States while vaping is currently behind both.

Similarly, a JAMA poll published last year indicated a shift in public perception, with more people considering smoking cannabis or secondhand marijuana smoke exposure as safer compared to tobacco smoke.

The YouGov poll also revealed that a significant majority of Americans — 62% — support marijuana legalization. This sentiment cuts across political affiliations, with 46% of Republicans, 67% of independents and 71% of Democrats expressing support for legalization.

Regarding usage patterns, 56% admitted to trying cannabis in their lifetime, with 24% reporting consumption within the past year and 17% within the last 30 days. Among those who consumed marijuana in the past year, 24% used it several times daily, 11% used it once daily and 20% used it occasionally.

According to the survey, smoking bud or flower was the most popular (61%) form of use among those who have tried cannabis or CBD. Furthermore, if cannabis were to be legalized countrywide, 67% of nonusers stated that they would keep abstaining. Another 14% expressed uncertainty about trying it, while 6% said they likely would, and 2% said they certainly would.

Meanwhile, another recent survey revealed that more than one-half of the adult population was surprised by the fact that cannabis remains federally illegal in the United States.

Furthermore, a Pew Research Center survey found that 90% of Americans support the legalization of cannabis for either medical or recreational purposes. Most respondents stated that legalization enhances equity in the criminal justice system and helps the local economy.

As perceptions toward marijuana keep changing, cannabis companies such as SNDL Inc. (NASDAQ: SNDL) could see their clientele growing in the different markets in which they have operations.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of an article each business day at 4:20 p.m. Eastern – a tribute to the time synonymous with cannabis culture. The concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive SMS alerts from CNW, text CANNABIS to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: https://www.CannabisNewsWire.com/Disclaimer

CannabisNewsWire
Denver, CO
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is powered by IBN

BizCann Expo Brings Cannabis Business to Latin America

BizCann invites traders, vendors, entrepreneurs, regulatory authorities, investors, and cannabis enthusiasts, to attend the BizCann Expo being held in Medellin, Colombia, May 18-19, 2024. The BizCann Expo is organized by ZJ Events, bringing the businesses and professionals of the cannabis industry and its ancillaries to a common forum for networking, trading, and learning sessions.

Having spread its reach over several cities in the US, BizCann Expo is being held in Medellin, Colombia, this year to offer phenomenal trading opportunities to local businesses. Due to its favorable location, connectivity, and rich history, Medellin offers the perfect venue for hosting this networking event.

In the year 2023, the event witnessed 50+ speakers, 200+ vendors, and 5,000+ attendees who connected over two days of networking and learning at the BizCann Expo. This year the participation is expected to outgrow last year’s numbers. Industry professionals with fresh and unique ideas can leverage this expo forum to gain visibility among peers, industry giants, and investors.

Entrepreneurs and creative minds with unique business ideas can share their innovations on this platform. Several eminent industry leaders will attend the expo to discuss the latest updates and strategies for successful canna trading. Plant-touching and non-plant touching cannabis businesses will also be represented at the Expo.

The speaker sessions will be conducted by stalwarts of the cannabis industry who have years of knowledge and experience of trading in this industry. They will discuss the latest updates, regulations, challenges, and prospects that lay ahead for businesses to grow and prosper. (Applications for speaker sessions are open.)

To learn more, please visit https://cnw.fm/fsryx

About CannabisNewsWire

CannabisNewsWire (“CNW”) is a specialized communications platform with a focus on cannabis news and the cannabis sector. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled recognition and brand awareness. CNW is where breaking news, insightful content and actionable information converge.

To receive SMS alerts from CNW, text CANNABIS to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: https://www.CannabisNewsWire.com/Disclaimer

CannabisNewsWire
Denver, CO
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is powered by IBN

Vape South America is Coming to Medellín

The ZJ Events Vape South America 2024 will be held at the Plaza Mayor Convention Center, Medellin Colombia, May 18-19, 2024. Top manufacturers, buyers, suppliers, users, traders, enthusiasts, and stalwarts of the alternative products industry will be attending the always popular event.

The counterculture and vape trade show will showcase a myriad of alternative products that include herbal products, mood enhancers, vape products, functional beverages, dietary supplements, nootropics, and more.

Suppliers, traders, head shops, and several businesses from the alternative category, will be part of the Expo, to showcase their latest products and services. Attendees can leverage huge discounts, get amazing deals, and explore the most innovative products, all under the fun and exciting environment of the expo.

As traditional and mainstream marketing is difficult for alternative products, an exclusive channel must be available to market and showcase the alternative products. ZJ Events offers the counterculture industry a robust platform with their Alternative Products Expo, where the best of the industry influencers meet, connect, and collaborate.

The event offers:

  • Registered buyers and brands, with media and marketing partnerships
  • Mass exposure to new players, industries, and innovations in the counterculture realm
  • Investors and traders, for discovering new products and trends
  • Networking with industry veterans and distributors for network expansion and a better ROI
  • Updates on the latest industry regulations

Vape South America started as Vape Conventions in 2017, evolved into USA CBDEXPO, and has been known as Alternative Products Expo in the United States since 2021. Dedicated booths are available for traders and innovators where they can showcase their innovative ideas and brands. Businesses can opt for different categories of sponsorships like platinum, gold, silver, etc., for extensive marketing by the event organizers.

To learn more, please visit https://cnw.fm/JCHWf

About CannabisNewsWire

CannabisNewsWire (“CNW”) is a specialized communications platform with a focus on cannabis news and the cannabis sector. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled recognition and brand awareness. CNW is where breaking news, insightful content and actionable information converge.

To receive SMS alerts from CNW, text CANNABIS to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: https://www.CannabisNewsWire.com/Disclaimer

CannabisNewsWire
Denver, CO
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is powered by IBN

420 with CNW — Is Cannabis Legalization Addressing Harms Minority Communities Suffered?

In 2014, Washington state marked a milestone by opening some of the country’s pioneering legal cannabis stores. At that time, Sam Ward Jr. found himself under home detention due to federal narcotics charges. He eventually went to prison to complete a four-year prison sentence.

Fast forward to today, Ward, a Black American citizen, proudly stands as the CEO of Cloud 9 Cannabis, his own marijuana store. Perched atop a colorful blue and gold throne, he extends a kind greeting to customers looking for early 4/20 discounts while reflecting on his experiences as one of the first to profit from Washington’s effort to open up the cannabis market to people affected by the drug war.

“It’s a remarkable feeling knowing that I’m steering a business, with employees counting on me,” Ward stated. “Simply being a part of something bigger brings immense satisfaction.”

A primary rationale behind legalizing recreational marijuana was to mitigate the harm caused by the uneven application of drug laws, which disproportionately affected communities of color such as Latino and Black communities. Studies consistently reveal that despite similar rates of marijuana use, minorities faced higher incarceration rates compared to their white counterparts.

However, efforts aimed at enabling those most impacted to engage in and benefit from the legal cannabis industry have encountered obstacles. While 24 states and the District of Columbia have embraced legal recreational cannabis use, nearly all have implemented social-equity programs to address the injustices of the drug war.

These encompass various measures, including expunging certain marijuana-related convictions, facilitating access to marijuana licenses and financial aid for individuals with prior marijuana convictions, and allocating cannabis tax revenues to affected communities.

Each state has its own criteria for determining eligibility for social-equity cannabis licenses, which may not exclusively hinge on race. For instance, in Washington, eligibility hinges on factors such as owning more than one-half of the entity, residing for a significant period in areas with marijuana-related arrests, unemployment, high poverty rates, or households with below-median income.

These programs’ execution has been hampered by legal challenges, such as in New York. Currently, New York is facing a new lawsuit despite having settled previous ones, that claims prejudice against minority-owned and women applicants and individuals affected by the war on drugs.

Moreover, concerns arise over large corporations with multistate operations obtaining licenses through social equity, potentially undermining its purpose. In Arizona, legislators raised alarms over licensees’ perceptions of being coerced into ceding power by predatory businesses.

Challenges extend to securing suitable locations due to local bans on marijuana businesses and obtaining bank financing amid federal prohibition. Ironically, factors qualifying individuals for licenses, such as residing in impoverished neighborhoods or having criminal records, hinder their ability to secure necessary funds.

David Penn Jr., another recipient of a social-equity license, faces similar challenges in establishing his marijuana business in Pasco, Washington. Despite financial backing from a friend, he grapples with the reality that grants alone may not suffice to overcome the hurdles he faces.

Washington, a trailblazer in marijuana legislation, recently initiated its social-equity initiative in 2020. However, only in recent months have the first licenses under the program been issued, with only two, including Ward’s store, currently operational.

The state, benefiting from substantial cannabis taxes, has allocated $8 million in grants to assist licensees in the social-equity program with expenses such as renovations, security systems and business coaching. Additionally, $250 million is directed toward communities affected by the war on drugs, supporting initiatives including job training, housing aid, violence prevention and business loans.

As states continue to grapple with the complexities of social equity in the cannabis industry, the experiences of individuals such as Ward and Penn serve as both a testament to progress made and a reminder of the work that remains to be done.

As the challenges faced by social-equity initiatives are addressed, other existing benefits will keep growing for ancillary enterprises such as Innovative Industrial Properties Inc. (NYSE: IIPR) that have carved out a niche for themselves by serving entities directly involved in regulated cannabis operations.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of an article each business day at 4:20 p.m. Eastern – a tribute to the time synonymous with cannabis culture. The concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive SMS alerts from CNW, text CANNABIS to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: https://www.CannabisNewsWire.com/Disclaimer

CannabisNewsWire
Denver, CO
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is powered by IBN

CannabisNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Announces $4.7M Warrant Exercise Agreement

Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug-delivery platforms, has entered into a warrant exercise agreement with an existing accredited investor to exercise in full existing warrants. Specifically, the agreement is comprised of the purchase of 2,917,032 shares of common stock, as to 1,618,330 warrants exercised at an exercise price of $0.97 per share, and 1,298,702 warrants exercised at $2.185 per share; the shares and warrants were originally issued in October 2023 and February 2024, respectively. The company noted that following this exercise, there are no remaining warrants exercisable at $0.97 and 259,741 warrants unexercised at $2.185. According to the announcement, the exercise agreement is expected to result in $4.7 million in gross proceeds for Lexaria, before standard deductions and expenses; the company anticipates using the funds for working capital and other general corporate purposes. The announcement also noted that, in consideration for the early exercise of the existing warrants for cash, and the payment of $0.125 per each new warrant, the company is issuing 2,917,032 new warrants, each new warrant entitling the holder to purchase one new share of common stock. The new warrants are immediately exercisable at an exercise price of $4.75 per share and will expire on Feb. 16, 2029, if not exercised before that date. “These additional cash proceeds of $4.7 million further extend Lexaria’s operational runway deep into 2025 and allow us to execute our 2024 plans at an aggressive pace,” said Lexario CEO Chris Bunka in the press release. “The exercise price of the replacement warrants, at $4.75, is a significant premium to current market prices and, in our opinion, a sign of confidence in Lexaria’s future.”

To view the full press release, visit https://cnw.fm/nhjd7

About Lexaria Bioscience Corp.

Lexaria Bioscience’s patented drug-delivery formulation and processing platform technology, DehydraTECH(TM), improves the way active pharmaceutical ingredients (“APIs”) enter the bloodstream through oral delivery. Since 2016, Lexaria has developed and investigated DehydraTECH with a variety of beneficial molecules in oral and topical formats. DehydraTECH has repeatedly demonstrated the ability to increase bioabsorption and has also evidenced an ability to deliver some drugs more effectively across the blood brain barrier, which Lexaria believes to be of particular importance for centrally active compounds. Lexaria operates a licensed, in-house research laboratory and holds a robust intellectual property portfolio with 41 patents granted and many patents pending worldwide. For more information about the company, please visit www.LexariaBioscience.com.

NOTE TO INVESTORS: The latest news and updates relating to LEXX are available in the company’s newsroom at https://cnw.fm/LEXX

About CannabisNewsWire

CannabisNewsWire (“CNW”) is a specialized communications platform with a focus on cannabis news and the cannabis sector. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled recognition and brand awareness. CNW is where breaking news, insightful content and actionable information converge.

To receive SMS alerts from CNW, text CANNABIS to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: https://www.CannabisNewsWire.com/Disclaimer

CannabisNewsWire
Denver, CO
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is powered by IBN

420 with CNW — More States Could Mark Upcoming 4/20s with Legal Access to Marijuana

Marijuana remains prohibited under federal law in the United States, yet a significant number of states have opted to legalize its recreational use. Currently, 24 states and the District of Columbia (“DC”) have passed legislation permitting recreational cannabis, as reported by the National Organization for the Reform of Marijuana Laws (NORML). Additionally, 38 states and DC have established regulations allowing for medical cannabis usage.

A recent survey conducted by the Pew Research Center highlights that a large majority of American adults, accounting for 88%, advocate for the legalization of marijuana. Within this majority, 32% express support for its legalization solely for medical purposes, while 57% endorse legalization for both recreational and medical use.

This year, the trend of legalizing recreational cannabis is continuing in various states. Notably, Florida is moving forward with a measure proposed by Smart and Safe Florida, which garnered more than a million signatures to put the measure on November’s ballot. The initiative seeks to legalize the recreational use of cannabis products and accessories for adults 21 years of age and older. Following approval by the state’s Supreme Court on April 1, 2024, the proposed amendment, known as Amendment 3, will be subjected to a vote by the public in November. However, achieving legalization in Florida necessitates a minimum of 60% of the vote in favor.

Similarly, a bill to legalize cannabis for recreational use at the beginning of January 2026 was recently passed by the state senate of Hawaii. Although the senate approved the bill with a vote of 19–6, hurdles are anticipated in the house. Florida Governor Josh Green has expressed support for the measure.

Meanwhile, New Hampshire’s House of Representatives endorsed a bill in April advocating for the legalization of cannabis and permitting adult usage. The bill proceeds to the senate for consideration, a step it has yet to undergo. New Hampshire Governor Chris Sununu, who previously opposed legalization, now acknowledges the majority support for it among residents and asserts his readiness to sign a legalization bill emphasizing harm reduction over profits.

Governor Josh Shapiro of Pennsylvania recently included the legalization of cannabis in his state budget proposal, prompting deliberation among state legislators. Likewise, in South Dakota, advocates are pushing to include cannabis legalization on the ballot for the third time. They must submit the requisite number of signatures by May 7, 2024, for the measure to be voted on in November, following previous setbacks in 2020 and 2022.

Established marijuana companies such as Green Thumb Industries Inc. (CSE: GTII) (OTCQX: GTBIF) are likely to follow the developments in the states looking to end prohibition as any reforms enacted there could widen the market for the existing players.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of an article each business day at 4:20 p.m. Eastern – a tribute to the time synonymous with cannabis culture. The concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive SMS alerts from CNW, text CANNABIS to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: https://www.CannabisNewsWire.com/Disclaimer

CannabisNewsWire
Denver, CO
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is powered by IBN